dapa totoDapagliflozin snificantly reduced risk of kidney failure and prolonged survival in patients with CKD with or without type 2 diabetes.Dapagliflozin snificantly reduced risk of kidney failure and prolonged survival in patients with CKD with or without type 2 diabetes.